Skip to content
ClinCalc Pro
Menu
Thyroid Hormone

Levothyroxine (Elderly)

Brand names: Eltroxin, Euthyrox

Used in: Thyroid Disorders

This page covers levothyroxine in older patients, the synthetic thyroid hormone (T4) used to treat hypothyroidism; in this group cautious initiation protects against cardiac effects.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is converted to active triiodothyronine (T3) and restores physiological thyroid hormone levels, normalising metabolic rate and tissue function.

Prescribing in practice

  • In older patients, and especially those with ischaemic heart disease, start at a low dose and titrate slowly, as rapid correction can precipitate angina, arrhythmia or myocardial ischaemia.
  • Take on an empty stomach and apart from interacting agents such as calcium and iron salts, which impair absorption; consistent timing relative to food and other drugs is important.
  • Over-replacement risks atrial fibrillation and accelerated bone loss, both of particular concern in older people.

Monitoring

Monitor thyroid function (TSH, with free T4) some weeks after initiation or dose changes and periodically thereafter, allowing time to reach steady state.

Counselling the patient

  • Take at the same time each day, usually before food, and separately from calcium or iron supplements.
  • Report palpitations, chest pain, tremor or unexpected weight change.
  • Do not change the dose yourself; adjustments are guided by blood tests.

Evidence & guidelines

UK thyroid guidance recommends low starting doses and gradual titration of levothyroxine in older patients and those with cardiac disease to avoid precipitating ischaemic events.

Reference: BTA/NICE guidelines; RCP guidance 2019; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.